...
首页> 外文期刊>International Journal of Clinical and Experimental Medicine >Biological effects of ray cartilage extract on human breast cancer cell line MCF-7 and its mechanism
【24h】

Biological effects of ray cartilage extract on human breast cancer cell line MCF-7 and its mechanism

机译:射线软骨提取物对人乳腺癌细胞MCF-7的生物学作用及其机制

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective: To explore the biological effects of ray cartilage extract (RCE) on human breast cancer cell line MCF-7 and its mechanism. Methods: MCF-7 cells were treated with RCE of different concentrations for different durations, and then MCF-7 cell proliferation was evaluated with MTT test, cell cycle was detected with flow cytometer and the protein levels of cyclin D1 and p21 were determined with Western blot. Results: MTT test indicated that MCF-7 cell proliferation was inhibited by RCE with an optimal inhibiting concentration of 10 μmol/L and an optimal action time of 48 h. Flow cytometer displayed that with the time prolongation of RCE action, the cells in S phase were significantly increased, but the cells in G2/M phase were significantly decreased; and MCF-7 apoptosis significantly increased as compared with blank control group (all P<0.05). Western blot found that with the time prolongation of RCE action, the level of cyclin D1 was significantly decreased, but the level of p21 was significantly increased as compared with blank control group (all P<0.05). Conclusion: RCE inhibits MCF-7 cell proliferation via arresting MCF-7 cell transformation from S phase to G2 phase. This may be associated with regulating the expressions of cyclin D1 and p21. RCE may be used as a drug for treatment of breast cancer in the future.
机译:目的:探讨射线软骨提取物(RCE)对人乳腺癌MCF-7细胞的生物学作用及其机制。方法:用不同浓度的RCE处理MCF-7细胞不同的时间,然后用MTT法评估MCF-7细胞的增殖,用流式细胞仪检测细胞周期,用Western法测定细胞周期蛋白D1和p21的蛋白水平。污点。结果:MTT试验表明,RCE抑制了MCF-7细胞的增殖,最佳抑制浓度为10μmol/ L,最佳作用时间为48 h。流式细胞仪显示,随着RCE作用时间的延长,S期细胞明显增多,而G2 / M期细胞明显减少。与空白对照组相比,MCF-7和MCF-7凋亡明显增加(所有P< 0.05)。 Western blot发现,随着RCE作用时间的延长,与空白对照组相比,细胞周期蛋白D1水平显着降低,而p21水平显着升高(所有P< 0.05)。结论:RCE通过抑制MCF-7细胞从S期到G2期的转化来抑制MCF-7细胞的增殖。这可能与调节细胞周期蛋白D1和p21的表达有关。 RCE将来可能会用作治疗乳腺癌的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号